Fifth Third Bancorp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-976
Closed -$25K 2383
2018
Q2
$25K Sell
976
-847
-46% -$19.7K ﹤0.01% 1594
2018
Q1
$37K Sell
1,823
-94
-5% -$2.19K ﹤0.01% 1444
2017
Q4
$38K Buy
1,917
+838
+78% +$16.5K ﹤0.01% 1368
2017
Q3
$22K Hold
1,079
﹤0.01% 1564
2017
Q2
$16K Hold
1,079
﹤0.01% 1614
2017
Q1
$17K Hold
1,079
﹤0.01% 1600
2016
Q4
$14K Sell
1,079
-178
-14% -$3.31K ﹤0.01% 1716
2016
Q3
$35K Buy
1,257
+384
+44% +$12.9K ﹤0.01% 1440
2016
Q2
$31K Buy
873
+24
+3% +$754 ﹤0.01% 1436
2016
Q1
$23K Sell
849
-155
-15% -$4.56K ﹤0.01% 1581
2015
Q4
$34K Buy
1,004
+298
+42% +$9.3K ﹤0.01% 1518
2015
Q3
$20K Sell
706
-72
-9% -$3.08K ﹤0.01% 1741
2015
Q2
$35K Buy
778
+278
+56% +$10.5K ﹤0.01% 1593
2015
Q1
$17K Buy
+500
New +$13.6K ﹤0.01% 1808

Other funds holding DPLO

Fifth Third Bancorp's DPLO Position: Q3 2018 in Review

Fifth Third Bancorp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 976 shares — an estimated $25K sold.

Fifth Third Bancorp first reported a position in DPLO in Q1 2015 and held it in 14 quarters. The position peaked at $38K in Q4 2017. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Fifth Third Bancorp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 976 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $25K.
  • Fifth Third Bancorp first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 14 quarters.
  • Fifth Third Bancorp's DIPLOMAT PHARMACY, INC. position peaked at $38K in Q4 2017.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Fifth Third Bancorp's 13F filing for Q3 2018, filed 14 Nov 2018.